Skip to Content
Showing 1-3 of 3

Sorted By:

  • BALANCE

    Balance is a double blind, placebo controlled phase 3 study of Akcea-APOCIII-LRX administered subcutaneously to patients with familial chylomicronemia syndrome (FCS).

  • CORE

  • ORION 4